Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment.
Biomedicines
; 6(1)2018 Mar 01.
Article
in En
| MEDLINE
| ID: mdl-29494517
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Biomedicines
Year:
2018
Document type:
Article
Affiliation country:
Germany
Country of publication:
Switzerland